Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions

Vaccine

Volumn 24, Issue 8, 2006, Pages 1063-1072

  Bahloul, Chokri ^a   Taieb, Dhoha ^a   Diouani, Mohamed Fethi ^a   Ahmed, Sami Ben Hadj ^a   Chtourou, Yassine ^a   B'chir, Beya Imen ^a   Kharmachi, Habib ^a   Dellagi, Koussay ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

DNA; Field conditions; Field trials; Rabies; Vaccine

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; RABIES VACCINE; RABITUN; TETRADOG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BREED; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; DRUG POTENCY; EAR; IMMUNOMODULATION; INJECTION; JET INJECTOR; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; RABIES; REARING; SINGLE DRUG DOSE; TUNISIA;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; VACCINATION; VACCINES, DNA;

EID: 32044459282     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.016     Document Type: Article

References (51)

1. WHO Rabies vaccines Weekly Epidemiol Rec 77 2002 109 120
2. A. Chadli Rabies in Tunisia. A comparative study of results from the last 36 years Archs Inst Pasteur Tunis 65 1988 15 27
3. C. Mitmoonpitak, V. Tepsumethanon, and H. Wilde Rabies in Thailand Epidemiol Infect 20 1998 165 169
4. FDA, Points to consider on plasmid DNA vaccines for preventive infectious disease indications, 1996, DOCKET No. 96N-0400.
5. WHO Tech Rep 878 1998 84 98
6. D.C. Tang, M. DeVit, and S.A. Johnston Genetic immunization is a simple method for eliciting an immune response Nature 356 1992 152 154
7. R.R. MacGregor, J.D. Boyer, K.E. Ugen, K.E. Lacy, S.J. Gluckman, and M.L. Bagarazzi First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J Infect Dis 178 1998 92 100
8. T.P. Le, K.M. Coonan, R.C. Hedstrom, Y. Charoenvit, M. Sedegah, and J.E. Epstein Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers Vaccine 18 2000 1893 1901
9. R.R. MacGregor, J.D. Boyer, R.B. Ciccarelli, R.S. Ginsberg, and D.B. Weiner Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data J Infect Dis 181 2000 406
10. M.A. Liu DNA vaccines: a review J Int Med 253 2003 402 410
11. P.L. Lodmell, N.B. Ray, M.J. Parnell, L.C. Ewalt, C.A. Hanlon, and J.H. Shaddock DNA immunization protects nonhuman primates against rabies virus Nat Med 8 1998 949 952
12. J.B. Ulmer, C.M. DeWitt, M. Chastain, A. Friedman, J.J. Donnelly, and W.L. McClements Enhancement of DNA vaccine potency using conventional aluminum adjuvants Vaccine 18 1999 18 28
13. S.E. Parker, P. Monteith, H. Horton, R. Hof, P. Hernandez, and A. Vilalta Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine Gene Ther 8 2001 1011 1023
14. J.J. Kim, J. Yang, K.H. Manson, and P.B. Weiner Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants Vaccine 19 2001 2496 2505
15. M.J. Roy, M.S. Wu, L.J. Barr, J.T. Fuller, L.G. Tussey, and S. Speller Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine Vaccine 19 2000 764 778
16. W.E. Swain, D. Heydenburg Fuller, M.S. Wu, L.J. Barr, J.T. Fuller, and J. Culp Tolerability and immune responses in humans to a Powder Ject DNA vaccine for hepatitis B Dev Biol 104 2000 115 119
17. P. Lundholm, A.C. Leandersson, B. Christensson, G. Bratt, E. Sandstrom, and B. Wahren DNA mucosal HIV vaccine in humans Virus Res 82 2002 141 145
18. P. Lundholm, Y. Asakura, J. Hinkula, E. Lucht, and B. Wahren Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA Vaccine 17 1999 2036 2042
19. G. Widera, M. Austin, D. Rabussay, C. Goldbeck, S.W. Barnett, and M. Chen Increased DNA vaccine delivery and immunogenicity by electroporation in vivo J Immunol 164 2000 4635 4640
20. S. Zucchelli, S. Capone, E. Fattori, A. Folgori, A. Di Marco, and D. Casimiro Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer J Virol 74 2000 11598 11607
21. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 1998 10180 10188
22. J. Schneider, S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, and C.M. Hannan Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat Med 4 1998 397 402
23. M. Sedegah, W. Weiss, J.B. Sacci Jr., Y. Charoenvit, R. Hedstrom, and K. Gowda Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus J Immunol 164 2000 5905 5912
24. Z.Q. Xiang, S. Spitalnik, M. Tran, W.H. Wunner, J. Cheng, and H.C. Ertl Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus Virology 199 1994 132 140
25. H.C. Ertl, P. Verma, Z. He, and Z.Q. Xiang Plasmid vectors as anti-viral vaccines Ann NY Acad Sci 772 1995 77 87
26. C. Bahloul, Y. Jacob, N. Tordo, and P. Perrin DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the Lyssaviruses Vaccine 16 1998 417 425
27. D.L. Lodmell, N.B. Ray, and L.C. Ewalt Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection Vaccine 16 1998 115 118
28. N.B. Ray, L.C. Ewalt, and D.L. Lodmell Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection Vaccine 15 1997 892 895
29. D.L. Lodmell, and L.C. Ewalt Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines Vaccine 18 2000 2394 2398
30. D.L. Lodmell, N.B. Ray, J.T. Ulrich, and L.C. Ewalt DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL) Vaccine 18 2000 1059 1066
31. D.L. Lodmell, and L.C. Ewalt Post-exposure DNA vaccination protects mice against rabies virus Vaccine 19 2001 2468 2473
32. C. Bahloul, S. Ben Hadj Ahmed, B.I. B'chir, H. Kharmachi, E.A. Hayouni, and K. Dellagi Post-exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine Vaccine 22 2003 177 184
33. P.L. Lodmell, M.J. Parnell, J.R. Bailey, L.C. Ewalt, and C.A. Hanlon One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination Vaccine 20 2001 838 844
34. J.E. Osorio, C.C. Tomlinson, R.S. Frank, E.J. Haanes, K. Rushlow, and J.R. Haynes Immunization of dogs and cats with a DNA vaccine against rabies virus Vaccine 17 1999 1109 1116
35. P. Perrin, Y. Jacob, A. Aguilar-Setien, E. Loza-Rubio, C. Jallet, and E. Desmezieres Immunization of dogs with a DNA vaccine induces protection against rabies virus Vaccine 18 1999 479 486
36. D.L. Lodmell, M.J. Parnell, J.T. Weyhrich, and L.C. Ewalt Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody Vaccine 21 2003 3998 4002
37. C. Seghaier, F. Cliquet, S. Hammami, T. Aouina, A. Tlatli, and M. Aubert Rabies mass vaccination campaigns in Tunisia: are vaccinated dogs correctly immunized? Am J Trop Med Hyg 61 1999 879 884
38. P. Kitala, J. McDermott, M. Kyule, J. Gathuma, B. Perry, and A. Wandeler Dog ecology and demography information to support the planning of rabies control in Machakos District, Kenya Acta Trop 78 2001 217 230
39. B. Chokri, T. Dhoha, K. Belhassen, F.D. Mohamed, A. Sami Ben Hadj, and C. Yacine Comparative evaluation of the ELISA and RFFIT antibody assay techniques in the assessment of the efficiency of rabies vaccination in dogs Epidemiol Infect 133 2005 749 757
40. W. Tepsumethanon, C. Polsuwan, B. Lumlertdaecha, P. Khawplod, T. Hemachudha, and S. Chutivongse Immune response to rabies vaccine in Thai dogs: a preliminary report Vaccine 9 1991 627 630
41. W.R. Heath, G.T. Belz, G.M. Behrens, C.M. Smith, S.P. Forehan, and I.A. Parish Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens Immunol Rev 199 2004 9 26
42. J.B. Ulmer, R.R. Deck, C.M. DeWitt, J.I. Donnelly, and M.A. Liu Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells Immunology 89 1996 59 67
43. S. Casares, K. Inaba, T.D. Brumeanu, R.M. Steinman, and C.A. Bona Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope J Exp Med 186 1997 1481 1486
44. J. Ulmer, J. Sadoff, and M. Liu DNA vaccines Curr Opin Immunol 8 1996 531 536
45. P. Forg, P. Von Hoegen, W. Dalemans, and V. Schirrmacher Superiority of the ear pinna over muscle tissue as site for DNA vaccination Gene Ther 5 1998 789 797
46. P. Precausta, J.P. Soulebt, M. Bugand, A. Brun, and Chappuis G. Modalities of production and immunity conferred by an inactivated rabies vaccine originating from cell culture Comp Immunol Microbiol Infect Dis 5 1982 217 226
47. Y. Wang, Z. Xiang, S. Pasquini, and H.C. Ertl Immune response to neonatal genetic immunization Virology 228 1997 278 284
48. C.U. Iroegbu, and E. Uhuegbu Incidence of rabies virus complement-fixing antibodies in unvaccinated dogs, humans and livestock in Anambra State of Nigeria Microbiologica 15 1992 213 217
49. A.B. Ogunkoya, G.W. Beran, J.U. Umoh, N.E. Gomwalk, and I.A. Abdulkadir Serological evidence of infection of dogs and man in Nigeria by lyssaviruses (family Rhabdoviridae) Trans R Soc Trop Med Hyg 84 1990 842 845
50. L.O. Wosu, and H.N. Anyanwu Seroepidemiological survey of rabies virus antibodies in non-vaccinated dogs in Nsukka Environs, Nigeria J Commun Dis 22 1990 124 128
51. M.L. East, H. Hofer, J.H. Cox, U. Wulle, H. Wiik, and C. Pitra Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas Proc Natl Acad Sci USA 98 2001 15026 15031